How to screen and treat gestational diabetes mellitus (GDM) has always been controversial for clinicians and decision makers. The problem is complex, and the evidence is limited. The new standards set by the American Diabetes Association (ADA) in 2011 (1) recommend 1) universal screening at 24–28 weeks of gestation (2010 ADA standards recommended selective screening based on risk factors) and 2...

Pregnant women with gestational diabetes mellitus (GDM) are at risk for certain neonatal complications. The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) blood glucose level (BGL) diagnostic thresholds correspond to an odds ratio of at least 1.75 for selected complications (1). In the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (2), 16.1% of subjects...

Gestational diabetes mellitus (GDM) is a metabolic alteration frequently found in pregnant women. In women with GDM, failure of pancreatic beta-cells to adapt the production of insulin at the increased metabolic demand in pregnancy, results in a inadequate insulin response, with consequent hyperglycemia. The criteria currently used for the diagnosis of GDM are too restrictive as some author sug...

The World Health Organization (WHO) has recently released a new classification and diagnostic criteria for hyperglycemia first diagnosed in pregnancy (1). These new criteria are an update of the 1999 WHO criteria, which defined gestational diabetes mellitus (GDM) as diabetes or impaired glucose tolerance with onset or first recognition in pregnancy. This definition was not based on a review of ...

O diabetes gestacional (DG) é uma das intercorrências mais frequentes da gestação e, se não diagnosticado e tratado adequadamente, traz aumento considerável dos riscos perinatais. As principais complicações são: macrossomia fetal, tocotraumas, aumento do número de cesáreas, hipoglicemia nenonatal, hiperbilirrubinemia neonatal, síndrome do desconforto respiratório do recém-nascido, hipocalcemia,...